Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Vioxx Strategy Aims To Switch Patients Up From OTC To Rx Market

Dec 20 1999

• By The Pink Sheet

Related Content

Celebrex Labeling For Polyps Should Emphasize Adjunctive Role, Cmte. Says

Dec 20 1999

Wyeth Fosamax Co-Promotion Deal With Merck Ends Jan. 1

Dec 20 1999

Celebrex Educational Campaign Or Name Change Expected By End Of May

May 10 1999

BI's Mobic NDA May Test Limits Of FDA COX-2 Class Definition

Dec 21 1998

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window